Endocrinology, Vol 124, 2089-2098, Copyright © 1989 by Endocrine Society

ARTICLES

Neuropeptide-Y stimulation of luteinizing hormone-releasing hormone secretion from the median eminence in vitro by estrogen-dependent and extracellular Ca2+-independent mechanisms

FD Sabatino, P Collins and JK McDonald
Department of Anatomy and Cell Biology, Emory University School of Medicine, Atlanta, Georgia 30322.

The roles of estrogen and extracellular calcium (Ca2+) in neuropeptide- Y (NPY)-stimulated LHRH release from median eminence (ME) fragments in vitro were examined. Ovariectomized (OVX) rats received one or several sc implants of Silastic tubes containing estradiol benzoate (235 micrograms/ml sesame oil) or vehicle. Plasma estrogen concentrations were similar to levels during the estrous cycle. These estrogen treatments were equally effective in reducing the elevated plasma levels of LH in vehicle-treated OVX rats. Animals were killed 3 days after implantation, and ME fragments were incubated in medium for 30 min (control), followed by a second 30-min period (test) in medium containing NPY or potassium chloride (K+). Estrogen treatment increased the basal release of LHRH and the ME concentration of LHRH in a dose- related fashion. NPY (0.1-10 microM) increased LHRH secretion in a dose- related manner from ME fragments obtained from estrogen-treated OVX rats, but had no effect on MEs from hormonally untreated OVX rats. Treatment with higher doses of estrogen enhanced the LHRH secretory response of ME fragments to NPY (1-10 microM). K+-stimulated LHRH release from ME fragments from estrogen-treated rats was completely eliminated in Ca2+-free medium containing EGTA. In contrast, LHRH release elicited by NPY (10 microM) was unchanged in Ca2+-free medium in both the absence and presence of cobalt chloride (Co2+). Decreasing the Ca2+ concentration from 2.5 to 0.25 mM reduced K+-stimulated LHRH release 7-fold, while NPY-stimulated LHRH secretion was not affected. These results indicate that NPY stimulation of LHRH release from the ME in vitro is related to prior circulating levels of estrogen, but does not require extracellular Ca2+ in the incubation medium. NPY may enhance LHRH release in an estrogen-dependent manner during the estrous cycle and before the LH surge on proestrous.

This article has been cited by other articles:

				I. J. Clarke, K. Backholer, and A. J. Tilbrook Y2 Receptor-Selective Agonist Delays the Estrogen-Induced Luteinizing Hormone Surge in Ovariectomized Ewes, but Y1-Receptor-Selective Agonist Stimulates Voluntary Food Intake Endocrinology, February 1, 2005; 146(2): 769 - 775. [Abstract] [Full Text] [PDF]

				E. H. Sohn, T. Wolden-Hanson, and A. M. Matsumoto Testosterone (T)-Induced Changes in Arcuate Nucleus Cocaine-Amphetamine-Regulated Transcript and NPY mRNA Are Attenuated in Old Compared to Young Male Brown Norway Rats: Contribution of T to Age-Related Changes in Cocaine-Amphetamine-Regulated Transcript and NPY Gene Expression Endocrinology, March 1, 2002; 143(3): 954 - 963. [Abstract] [Full Text] [PDF]

				M. Xu, J. H. Urban, J. W. Hill, and J. E. Levine Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors Endocrinology, September 1, 2000; 141(9): 3319 - 3327. [Abstract] [Full Text] [PDF]

				M. Mizuno, M. Gearing, and E. Terasawa The Role of Neuropeptide Y in the Progesterone-Induced Luteinizing Hormone-Releasing Hormone Surge in Vivo in Ovariectomized Female Rhesus Monkeys Endocrinology, May 1, 2000; 141(5): 1772 - 1779. [Abstract] [Full Text] [PDF]